Skip to main content
. 2020 Mar 30;15(3):e0230730. doi: 10.1371/journal.pone.0230730

Table 2. Number of people with available data and crude prevalence (%) of cardiovascular disease (CVD) risk factors and of risk of CVD by population.

HIV-Infected (N = 5839) General population (N = 4820) p-value
N Crude prevalence (95% CI) Crude Prevalence (95% CI) after MIa N Crude weighted Prevalence (95% CI)
Hypertension 2057 35.6 (33.6, 37.7) 34.4 (32.6, 36.3) 4751 41.1 (39.3, 43.0) <0.001
Diabetes 5703 7.2 (6.5, 7.9) 7.2 (6.6, 7.9) 4391 11.3 (10.2, 12.5) <0.001
Dyslipidemia 5661 48.6 (47.3, 49.9) 48.7 (47.4, 50.0) 4419 44.1 (42.1, 46.1) <0.001
Current smoking 3047 58.5 (56.7, 60.2) 59.1 (57.6, 60.6) 4711 38.7 (36.7, 40.7) <0.001
Obesity 2143 10.6 (9.4, 12.0) 15.8 (14.6, 17.1) 4761 33.4 (31.6, 35.2) <0.001
High FRSb 1266 20.1 (18.0, 22.4) 16.6 (15.5, 17.8) 4145 27.3 (25.6, 29.0) <0.001
FRSb (Mean, 95% CI) 1266 12.3 (11.6, 13.1) 11.2 (10.9, 11.6) 4145 15.5 (14.8, 16.2) <0.001
High SCOREb 1158 5.4 (4.2, 6.8) 5.4 (4.7, 6.2) 3577 17.3 (15.9, 18.8) <0.001
SCOREb (Mean, 95%CI) 1158 1.2 (1.0, 1.3) 1.2 (1.1, 1.3) 3577 2.8 (2.6, 3.0) <0.001

a: Crude prevalence estimated after filling in missing data in the AMACS patients using the multiple imputation (MI) method.

b: Framingham risk score (FRS) used to estimate the 10-year risk of fatal and non-fatal CVD and the Systematic Coronary Risk Evaluation (SCORE) to estimate the 10-year risk of fatal CVD. FRS risk ≥20% (High FRS) and SCORE risk score ≥5% (High SCORE) were considered as high risk. FRS was estimated for those aged>20 years and SCORE for non-diabetics aged >20years.